News on NASH

Video Courtesy of The NASH Education Program™



Click here for a brief synopsis. Video Courtesy of Pinnacle Clinical Research and AASLD TV


HistoIndex Is Now MedTech Imaging Partner of Strategic Colla...

Date: 11 Mar 2020

HistoIndex is very happy to be on board this strategic research collaboration by A*STAR's GIS, NUS Medicine and Novo Nordisk as one of the MedTech imaging partners.

Our AI-based stain-free digital pathology platform will contribute towards identifying patients with nonalcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), by providing a precise quantification of NAFLD/NASH characteristics.

Read More

Pinnacle Clinical Research: A HistoIndex Global Partner

Date: 27 May 2019

[Video Courtesy of Pinnacle Clinical Research] Pinnacle Clinical Research is dedicated towards the study and clinical trials on liver diseases, particularly Nonalcoholic Steatohepatitis (NASH), and working hard in the NASH frontier with his team is Dr Stephen Harrison. As partners, HistoIndex and Pinnacle have been working hand-in-hand to achieve the ultimate outcome: Getting the most effective treatments to NASH patients. 
Read More

Assessing and Quantifying Hepatic Steatosis with Second Harm...

Date: 08 Mar 2019

A study by the Singapore General Hospital (SGH) demonstrates that Second Harmonic Generation (SHG) and Two-photon Excitation Fluorescence (TPEF) by HistoIndex can be used to precisely quantify Hepatic Steatosis (HS) in a continuous-scale measurement, and also detect subtle interval nuances that may not be very apparent with the use of traditional approaches.

This novel SHG/TPEF method is very relevant as a crucial tool in the current clinical trials interrogating the effectiveness of therapeutic agents for NAFLD and NASH.


Read More

Helping Histopathologists to Efficiently and Accurately Asse...

Date: 02 Aug 2018

Results from a recent study by a team of clinicians from Singapore validates the reliability of SHG microscopy – by HistoIndex’s Genesis®200 – as an automated and accurate method for fibrosis staging. This assessment tool adds significant value to a histopathologist’s efficiency and reliability in his/her routine clinical practice.

Read More

World Hepatitis Day: message from WHO Director-General

Date: 26 Jul 2018

A video message by the World Health Organization (WHO) Director-General Dr Tedros on the occasion of World Hepatitis Day 2018.

Read More

Amid Obesity Epidemic, Liver Cancer Deaths Surge

Date: 17 Jul 2018

[Report by MedPage Today] The death rate for liver cancer increased by 43% since 2000, a new report from the CDC indicated, with fingers pointing to the obesity epidemic as the main root cause.

Read More

12 superfoods that boost immunity in children

Date: 10 Jul 2018

[Report from The Health Site] Is your child having healthy food? Is he getting his quota of proteins? What about the antioxidants and vitamins? Now it’s too much work to sit and select food meticulously.

Here is a list of super foods that should surface in your child’s diet one way or the other to meet all the nutritional needs, help in growth and development and of course boost immunity.

Read More

Liver-friendly Recipes

Date: 04 Jul 2018

[Report by] Doctors and researchers agree that eating a well balanced diet containing the proper number of calories and an appropriate ratio of carbohydrates, proteins and fats are important for your overall health. For people with impaired liver function, proper nutrition takes on increasing importance. Eating liver friendly recipes not only helps protect and support your liver, but also helps your liver function better and regenerate new, healthy liver cells.

Read More

NASH may soon become most common liver transplant etiology

Date: 27 Jun 2018

[Report by Healio] Results of a recent study showed that nonalcoholic steatohepatitis was the most rapidly growing cause of hepatocellular carcinoma among U.S. patients listed for liver transplantation.

Read More

Love Your Liver Health Screener by the British Liver Trust.

Date: 20 Jun 2018

[From the British Liver Trust] Liver disease usually has no symptoms in the early stages and around three quarters of people are currently diagnosed when it is too late for effective treatment or intervention. 90% of liver disease is preventable. Finding out if you’re at risk of liver disease only takes a few minutes. 

The "Love Your Liver Health Screener"is brought to you by the British Liver Trust. Click this blogspot to find out more.

Read More

1 2 3 4 5 ... 7